Plenge Robert M 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Plenge Robert M（CIK 1773367）在 2 家公司共报告 10 笔 SEC Form 4 内部人交易（最近一笔 2026-09-14）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-14 | BIOMARIN PHARMACEUTICAL INC (BMRN) | 董事 | 买入 | 6,140 | $0 |
| 2026-03-12 | BRISTOL MYERS SQUIBB CO (BMY) | EVP, Chief Research Officer | 买入 | 1,107 | $0 |
| 2026-03-12 | BRISTOL MYERS SQUIBB CO (BMY) | EVP, Chief Research Officer | 卖出 | 124 | $0 |
| 2026-03-12 | BRISTOL MYERS SQUIBB CO (BMY) | EVP, Chief Research Officer | 卖出 | 436 | $26,217 |
| 2026-03-12 | BRISTOL MYERS SQUIBB CO (BMY) | EVP, Chief Research Officer | 买入 | 2,342 | $0 |
| 2026-03-12 | BRISTOL MYERS SQUIBB CO (BMY) | EVP, Chief Research Officer | 卖出 | 253 | $0 |
| 2026-03-12 | BRISTOL MYERS SQUIBB CO (BMY) | EVP, Chief Research Officer | 卖出 | 927 | $55,741 |
| 2026-03-12 | BRISTOL MYERS SQUIBB CO (BMY) | EVP, Chief Research Officer | 买入 | 14,052 | $0 |
| 2026-03-12 | BRISTOL MYERS SQUIBB CO (BMY) | EVP, Chief Research Officer | 卖出 | 6,900 | $0 |
| 2026-03-12 | BRISTOL MYERS SQUIBB CO (BMY) | EVP, Chief Research Officer | 卖出 | 3,172 | $190,732 |
来源：SEC Form 4 申报文件 · 截至 2026-09-14